214 related articles for article (PubMed ID: 2145065)
41. Role of laminin in the attachment and metastasis of murine tumor cells.
Terranova VP; Liotta LA; Russo RG; Martin GR
Cancer Res; 1982 Jun; 42(6):2265-9. PubMed ID: 7074609
[TBL] [Abstract][Full Text] [Related]
42. Differential effects of glycolipid biosynthesis inhibitors on ceramide-induced cell death in neuroblastoma cells.
Bieberich E; Freischütz B; Suzuki M; Yu RK
J Neurochem; 1999 Mar; 72(3):1040-9. PubMed ID: 10037475
[TBL] [Abstract][Full Text] [Related]
43. Rationales for cancer chemotherapy with PDMP, a specific inhibitor of glucosylceramide synthase.
Radin NS
Mol Chem Neuropathol; 1994; 21(2-3):111-27. PubMed ID: 8086032
[TBL] [Abstract][Full Text] [Related]
44. Metabolism of D-[3H]threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol, an inhibitor of glucosylceramide synthesis, and the synergistic action of an inhibitor of microsomal monooxygenase.
Shukla A; Radin NS
J Lipid Res; 1991 Apr; 32(4):713-22. PubMed ID: 1856614
[TBL] [Abstract][Full Text] [Related]
45. The glucosylceramide synthase inhibitor PDMP sensitizes pancreatic cancer cells to MEK/ERK inhibitor AZD-6244.
Wang T; Wei J; Wang N; Ma JL; Hui PP
Biochem Biophys Res Commun; 2015 Jan; 456(3):821-6. PubMed ID: 25498501
[TBL] [Abstract][Full Text] [Related]
46. Studies on transplantation of the laminin receptor and its roles in experimental metastasis of murine Lewis lung carcinoma cells.
Zhang QY; Zhou RL
Sci China B; 1992 Aug; 35(8):974-80. PubMed ID: 1301746
[TBL] [Abstract][Full Text] [Related]
47. Invasive activity, spreading on and chemotactic response to laminin are properties of high but not low metastatic mouse osteosarcoma cells.
Aresu O; Nicolò G; Allavena G; Melchiori A; Schmidt J; Kopp JB; d'Amore E; Chader GJ; Albini A
Invasion Metastasis; 1991; 11(1):2-13. PubMed ID: 2061001
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells.
Norris-Cervetto E; Callaghan R; Platt FM; Dwek RA; Butters TD
J Biol Chem; 2004 Sep; 279(39):40412-8. PubMed ID: 15263008
[TBL] [Abstract][Full Text] [Related]
49. Glucosylceramide biosynthesis is involved in Golgi morphology and protein secretion in plant cells.
Melser S; Batailler B; Peypelut M; Poujol C; Bellec Y; Wattelet-Boyer V; Maneta-Peyret L; Faure JD; Moreau P
Traffic; 2010 Apr; 11(4):479-90. PubMed ID: 20028486
[TBL] [Abstract][Full Text] [Related]
50. Activation of protein kinase A increases the in vitro invasion, migration, and adherence to reconstituted basement membrane by Lewis lung carcinoma tumor cells.
Young MR; Young ME; Lozano Y; Bagash JM
Invasion Metastasis; 1992; 12(5-6):253-63. PubMed ID: 1298738
[TBL] [Abstract][Full Text] [Related]
51. Identification of an Mr 64,000 plasma membrane glycoprotein mediating adhesion of tumor H-59 cells to hepatocytes.
Wang J; Fallavollita L; Brodt P
Cancer Res; 1991 Jul; 51(13):3578-84. PubMed ID: 2054793
[TBL] [Abstract][Full Text] [Related]
52. Glucosylceramide synthetase inhibitor, D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol exhibits a novel decarcinogenic activity against Shope carcinoma cells.
Kyogashima M; Inoue M; Seto A; Inokuchi J
Cancer Lett; 1996 Mar; 101(1):25-30. PubMed ID: 8625278
[TBL] [Abstract][Full Text] [Related]
53. Effects of an inhibitor of glucosylceramide synthase on glycosphingolipid synthesis and neurite outgrowth in murine neuroblastoma cell lines.
Uemura K; Sugiyama E; Taketomi T
J Biochem; 1991 Jul; 110(1):96-102. PubMed ID: 1834639
[TBL] [Abstract][Full Text] [Related]
54. Cell cycle arrest induced by an inhibitor of glucosylceramide synthase. Correlation with cyclin-dependent kinases.
Rani CS; Abe A; Chang Y; Rosenzweig N; Saltiel AR; Radin NS; Shayman JA
J Biol Chem; 1995 Feb; 270(6):2859-67. PubMed ID: 7852361
[TBL] [Abstract][Full Text] [Related]
55. A ceramide analogue inhibits T cell proliferative response through inhibition of glycosphingolipid synthesis and enhancement of N,N-dimethylsphingosine synthesis.
Felding-Habermann B; Igarashi Y; Fenderson BA; Park LS; Radin NS; Inokuchi J; Strassmann G; Handa K; Hakomori S
Biochemistry; 1990 Jul; 29(26):6314-22. PubMed ID: 2207076
[TBL] [Abstract][Full Text] [Related]
56. Pharmacological Modulation of Glycosphingolipid Metabolism.
Inokuchi JI; Ode T; Hara-Yokoyama M
Methods Mol Biol; 2018; 1804():401-410. PubMed ID: 29926420
[TBL] [Abstract][Full Text] [Related]
57. Glycosphingolipid synthesis is essential for MDCK cell differentiation.
Pescio LG; Favale NO; Márquez MG; Sterin-Speziale NB
Biochim Biophys Acta; 2012 Jun; 1821(6):884-94. PubMed ID: 22387616
[TBL] [Abstract][Full Text] [Related]
58. Glycosphingolipid deficiency affects functional microdomain formation in Lewis lung carcinoma cells.
Inokuchi JI; Uemura S; Kabayama K; Igarashi Y
Glycoconj J; 2000; 17(3 -4):239-45. PubMed ID: 11201796
[TBL] [Abstract][Full Text] [Related]
59. 1-phenyl-2-decanoylamino-3-morpholino-1-propanol chemosensitizes neuroblastoma cells for taxol and vincristine.
Sietsma H; Veldman RJ; Kolk D; Ausema B; Nijhof W; Kamps W; Vellenga E; Kok JW
Clin Cancer Res; 2000 Mar; 6(3):942-8. PubMed ID: 10741719
[TBL] [Abstract][Full Text] [Related]
60. Effects of glucosylceramide synthase inhibitor and ganglioside GQ1b on synchronous oscillations of intracellular Ca2+ in cultured cortical neurons.
Mizutani A; Kuroda Y; Muramoto K; Kobayashi K; Yamagishi K; Inokuchi J
Biochem Biophys Res Commun; 1996 May; 222(2):494-8. PubMed ID: 8670233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
